Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-22
1997-06-24
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544272, 544267, C07D47300, A61K 3152
Patent
active
056417845
ABSTRACT:
New xanthine compounds of formula I: ##STR1## wherein the substituents are defined herein, which xanthines are useful as adenosine antagonists.
REFERENCES:
patent: 4061753 (1977-12-01), Bodor et al.
patent: 4548820 (1985-10-01), Regnier et al.
patent: 4612315 (1986-09-01), Jacobson et al.
patent: 4755517 (1988-07-01), Bruns et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 5068236 (1991-11-01), Suzuki et al.
patent: 5290782 (1994-03-01), Susuki et al.
patent: 5525607 (1996-06-01), Susuki et al.
patent: 5532368 (1996-07-01), Kufner-Muhl et al.
Ensinger Helmut
Kufner-Muhl Ulrike
Kuhn Franz Josef
Lehr Erich
Schingnitz Gunter
Boehringer Ingelheim KG
Bond Robert T.
Devlin Mary-Ellen M.
Raymond Robert P.
Rieder Wendy E.
LandOfFree
8-substituted 1,3-dialiphaticxanthine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-substituted 1,3-dialiphaticxanthine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-substituted 1,3-dialiphaticxanthine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149402